| Literature DB >> 26335922 |
Francesco Lamanna1, Frank Kirschbaum2, Isabelle Waurick3, Christoph Dieterich4,5, Ralph Tiedemann6.
Abstract
BACKGROUND: African weakly-electric fishes of the family Mormyridae are able to produce and perceive weak electric signals (typically less than one volt in amplitude) owing to the presence of a specialized, muscle-derived electric organ (EO) in their tail region. Such electric signals, also known as Electric Organ Discharges (EODs), are used for objects/prey localization, for the identification of conspecifics, and in social and reproductive behaviour. This feature might have promoted the adaptive radiation of this family by acting as an effective pre-zygotic isolation mechanism. Despite the physiological and evolutionary importance of this trait, the investigation of the genetic basis of its function and modification has so far remained limited. In this study, we aim at: i) identifying constitutive differences in terms of gene expression between electric organ and skeletal muscle (SM) in two mormyrid species of the genus Campylomormyrus: C. compressirostris and C. tshokwe, and ii) exploring cross-specific patterns of gene expression within the two tissues among C. compressirostris, C. tshokwe, and the outgroup species Gnathonemus petersii.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26335922 PMCID: PMC4558960 DOI: 10.1186/s12864-015-1858-9
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Analyzed species. The three species analysed in this study, with their relative EODs. From bottom to top: G. petersii, C. compressirostris, C. tshokwe
Assembly statistics for the cross-tissue comparison
|
|
| |
|---|---|---|
| Trinity contigs | 260,598 | 369,030 |
| # of retrieved ORFs | 139,963 | 228,306 |
| # of unique PFAM domains | 9,986 | 9,941 |
| # of contigs matching | 108,705 | 159,263 |
| # of unique hits to | 18,458 | 19,363 |
| N50 | 3,010 | 3,597 |
| Average contig length | 1,392.16 | 1,672.28 |
| Total assembled bases | 362,794,286 | 617,123,151 |
Assembly statistics for the cross-species comparison
| SM | EO | |
|---|---|---|
| Trinity contigs | 357,832 | 399,878 |
| # of retrieved ORFs | 150,068 | 182,682 |
| # of unique PFAM domains | 10,374 | 10,752 |
| # of contigs matching | 193,516 | 232,755 |
| # of unique hits to | 20,023 | 20,352 |
| N50 | 2,299 | 2,345 |
| Average contig length | 1,119.38 | 1,149.25 |
| Total assembled bases | 400,549,148 | 459,560,613 |
Fig. 2Distribution of length coverage between Campylomormyrus Trinity transcripts and corresponding top-blast hits (D. rerio proteome). Histogram showing the distribution of the percent in length of the sequences in the D. rerio proteome that aligns to the assembled Trinity contigs. Numbers on the x-axis indicate the upper limit of the binned interval (e.g., 100 is the upper value of the interval 100–91). a Cross-tissue comparison. b Cross-species comparison
Fig. 3Number of differentially expressed genes (Cross-tissue). Venn diagram showing the amount of differentially expressed genes within each Campylomormyrus species’ transcriptome (full circles) and the amount of differentially expressed genes shared between the two Campylomormyrus species (overlapping area). The amount of genes that are up (EO[+])- or down (EO[−])-regulated in the electric organ are reported for each dataset
Fig. 4Principal component analysis of expression levels. Gnapet = G. petersii; comp = C. compressirostris; tsho = C. tshokwe; eo = electric organ; mu = skeletal muscle
Fig. 5Neighbour-joining analysis of expression levels. Neighbour-joining tree based on pairwise distance matrix (1 – ρ, Spearman’s correlation coefficient) for EO and SM expression values. Bootstrap replicates = 10,000. Circles at nodes indicate bootstrap support. Gnapet = G. petersii; comp = C. compressirostris; tsho = C. tshokwe; eo = electric organ; mu = skeletal muscle; rep = replicate
Fig. 6Cross-species analysis (SM). a Results of the DE analysis. Left: heatmap showing the differentially expressed genes clustered by expression levels. Expression sub-clusters obtained from k-mean clustering. Each cluster groups together genes characterized by similar expression levels. b Network showing significantly enriched terms and their relative genes for each sub-cluster
Fig. 7Cross-species analysis (EO). a Results of the DE analysis. Left: heatmap showing the differentially expressed genes clustered by expression levels. Expression sub-clusters obtained from k-mean clustering. Each cluster groups together genes characterized by similar expression levels. b Networks showing significantly enriched terms and their relative genes for each sub-cluster
Fig. 8Functional annotation results (Cross-tissue). Pie charts showing the composition in terms of enriched functional categories (GO) and pathways (KEGG, Reactome) for each cluster of differentially expressed genes. EO[+] = up-regulated in the electric organ; EO [−] = down-regulated in the electric organ
Electrical activity
| Gene | Protein name | Expression in EO | Pathway/Function | Disrupted phenotype | Reference |
|---|---|---|---|---|---|
| atp1a2a | ATPase, Na+/K+ transporting, alpha 2a polypeptide | + | Ion channel transport | Impaired depolarization of the resting membrane potential in slow-twitch fibers of skeletal muscles. | [ |
| chrna7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) | + | Activation of Nicotinic Acetylcholine Receptors | ||
| kcnj9 | potassium inwardly-rectifying channel, subfamily J, member 9 | + | Potassium Channels; GABA receptor activation | ||
| kcnq5a | potassium voltage-gated channel, KQT-like subfamily, member 5a | + | Potassium Channels; Synaptic transmission ion currents | ||
| grik3 | Glutamate Receptor, Ionotropic, Kainate 3 | + | Transmission across Chemical Synapses | ||
| scn4aa | sodium channel, voltage-gated, type IV, alpha, a | + | Ion channel transport; Axon guidance | ||
| kcna3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | - | Potassium Channels; Transmission across Chemical Synapses | ||
| kcnj12 | potassium inwardly-rectifying channel, subfamily J, member 12 | - | Potassium Channels; GABA receptor activation | ||
| cacna2d2 | calcium channel, voltage-dependent, alpha 2/delta subunit 2 | - | Ion channel transport |
For each of the shared differentially expressed gene are reported: the gene and protein names obtained from the top hit blast results against the proteome of D. rerio; whether it is up(+)- or down(−)- regulated in the EO; its function or pathway (or both when available); the phenotypic effect on D. rerio of its mis-expression (when available)
Muscular activity
| Gene | Protein name | Expression in EO | Pathway/Function | Disrupted phenotype | Reference |
|---|---|---|---|---|---|
| atp2a1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | - | Muscle contraction | Abnormal locomotion | [ |
| atp2a2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2a | - | regulation of heart contraction | Abnormal heart development | [ |
| casq1a | calsequestrin 1a | - | Calcium homeostasis | ||
| jph1a | junctophilin 1a | - | structural constituent of muscle | ||
| jph1b | junctophilin 1b | - | structural constituent of muscle | ||
| myl2a | myosin, light chain 2a, regulatory, cardiac, slow | - | Striated Muscle Contraction | ||
| mybpc2a | myosin binding protein C, fast type a | - | Striated Muscle Contraction | ||
| mybpc3 | myosin binding protein C, cardiac | - | Cardiac muscle contraction | Abnormal heart development | [ |
| myhb | myosin, heavy chain b | - | Striated Muscle Contraction | ||
| myl10 | myosin, light chain 10, regulatory | - | Regulation of actin cytoskeleton; Focal adhesion | ||
| myl12.2 | myosin, light chain 12, genome duplicate 2 | - | Striated Muscle Contraction | ||
| mylk2 | myosin light chain kinase 2 | - | Focal adhesion; Regulation of actin cytoskeleton | ||
| mylk3 | myosin light chain kinase 3 | - | Focal adhesion; Regulation of actin cytoskeleton | Cardiac sarcomere disruption | [ |
| mylpfb | myosin light chain, phosphorylatable, fast skeletal muscle b | - | Focal adhesion; Regulation of actin cytoskeleton | ||
| myo18ab | myosin XVIIIAb | - | Signaling by FGFR | ||
| myoz3a | myozenin 3a | - | Calcineurin signaling | ||
| nexn | nexilin (F actin binding protein) | - | cardiac muscle fiber development | ||
| parvb | parvin, beta | - | Focal adhesion; Cell junction organization | Abnormal trunk musculature development | [ |
| pdlim3b | PDZ and LIM domain 3b | - | |||
| pdlim5b | PDZ and LIM domain 5b | - | |||
| pvalb3 | parvalbumin 3 | - | calcium ion homeostasis | ||
| ryr1a | ryanodine receptor 1a (skeletal) | - | calcium ion channel transport | Abnormal trunk musculature development | [ |
| ryr1b | ryanodine receptor 1b (skeletal) | - | calcium ion channel transport | Abnormal trunk musculature development | [ |
| tnnc2 | troponin C type 2 (fast) | - | Striated Muscle Contraction | ||
| smpx | small muscle protein, X-linked | - | Striated Muscle Contraction | ||
| smyd1b | SET and MYND domain containing 1b | - | Muscle Development | Thick myosin filament disorganization | [ |
| srl | sarcalumenin | - | calcium ion homeostasis | ||
| stac3 | SH3 and cysteine rich domain 3 | - | Striated Muscle Contraction | Excitation–contraction coupling disruption | [ |
| tcap | titin-cap (telethonin) | - | Striated Muscle Contraction | Myofibril disorganization | [ |
| tmod4 | tropomodulin 4 (muscle) | - | Muscle contraction | ||
| tnnc1b | troponin C type 1b (slow) | - | Muscle contraction | ||
| tnni2b.2 | troponin I type 2b (skeletal, fast), tandem duplicate 2 | - | Striated Muscle Contraction | ||
| tnnt1 | troponin T type 1 (skeletal, slow) | - | Muscle contraction | ||
| tnnt3b | troponin T type 3b (skeletal, fast) | - | Striated Muscle Contraction | ||
| tpm1 | tropomyosin 1 (alpha) | - | Striated Muscle Contraction | ||
| tpm2 | tropomyosin 2 (beta) | - | Striated Muscle Contraction | ||
| trdn | triadin | - | Muscle contraction | ||
| trim54 | tripartite motif containing 54 | - | Titin-kinase regulation | ||
| xirp1 | xin actin-binding repeat containing 1 | - | |||
| myl13 | myosin, light chain 13 | - |
For each of the shared differentially expressed gene are reported: the gene and protein names obtained from the top hit blast results against the proteome of D. rerio; whether it is up(+)- or down(−)- regulated in the EO; its function or pathway (or both when available); the phenotypic effect on D. rerio of its mis-expression (when available)
Metabolism
| Gene | Protein name | Expression in EO | Pathway/Function | Disrupted phenotype | Reference |
|---|---|---|---|---|---|
| acsbg2 | acyl-CoA synthetase bubblegum family member 2 | - | Fatty acid metabolism | ||
| acsl3b | acyl-CoA synthetase long-chain family member 3b | + | Fatty acid metabolism | ||
| acy1 | Aminoacylase-1 | - | Aminoacids metabolism | ||
| adssl1 | adenylosuccinate synthase like 1 | - | Purine metabolism | ||
| aldoab | Fructose-bisphosphate aldolase | - | Glycolysis | ||
| ampd1 | Adenosine monophosphate deaminase 1 (Isoform M) | - | Purine metabolism | ||
| aoc2 | amine oxidase, copper containing 2 | + | beta-Alanine metabolism | ||
| cds1 | CDP-Diacylglycerol Synthase 1 | + | Glycerophospholipid biosynthesis | Imperfect angiogenesis | [ |
| ckma | creatine kinase, muscle a | - | Metabolism of amino acids and derivatives | ||
| ckmt2a | creatine kinase, mitochondrial 2a (sarcomeric) | - | Metabolism of amino acids and derivatives | ||
| cox4i2 | cytochrome c oxidase subunit IV isoform 2 | - | Oxidative phosphorylation | ||
| cpt2 | carnitine palmitoyltransferase 2 | + | Fatty acid beta-oxidation | ||
| cyp24a1 | cytochrome P450, family 24, subfamily A, polypeptide 1 | - | Steroid biosynthesis | ||
| dhrs9 | dehydrogenase/reductase (SDR family) member 9 | + | Retinol metabolism | ||
| gdpd4a | glycerophosphodiester phosphodiesterase domain containing 4a | + | Glycerol metabolism | ||
| gdpd5a | glycerophosphodiester phosphodiesterase domain containing 5a | + | Glycerol metabolism | ||
| gdpd5b | glycerophosphodiester phosphodiesterase domain containing 5b | + | Glycerol metabolism | ||
| glo1 | Glyoxalase 1 | - | Pyruvate metabolism | ||
| glud1b | glutamate dehydrogenase 1b | - | Nitrogen metabolism | ||
| got2a | glutamic-oxaloacetic transaminase 2a, mitochondrial | - | Glucose metabolism; aminoacids metabolism | ||
| gpib | glucose-6-phosphate isomerase b | - | Gluconeogenesis | ||
| idi1 | isopentenyl-diphosphate delta isomerase 1 | - | Cholesterol biosynthesis | ||
| man1a1 | mannosidase, alpha, class 1A, member 1 | + | N-Glycan biosynthesis | ||
| me3 | malic enzyme 1, NADP(+)-dependent, cytosolic | - | Pyruvate metabolism | ||
| pcyox1 | prenylcysteine oxidase 1 | - | Terpenoid backbone biosynthesis | ||
| pfkfb1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | - | Glycolysis | ||
| pgam2 | phosphoglycerate mutase 2 (muscle) | - | Glycolysis and Gluconeogenesis | ||
| pgm5 | Phosphoglucomutase 5 | - | Glucuronidation | Failure in myofibril assembly | [ |
| ucp3 | uncoupling protein 3 | - | Respiratory electron transport | ||
| ugp2b | UDP-glucose pyrophosphorylase 2b | - | Glucose metabolism | ||
| gyg1a | glycogenin 1a | - | Glycogen Metabolism | ||
| mid1ip1l | MID1 interacting protein 1, like | - | lipid metabolic process |
For each of the shared differentially expressed gene are reported: the gene and protein names obtained from the top hit blast results against the proteome of D. rerio; whether it is up(+)- or down(−)- regulated in the EO; its function or pathway (or both when available); the phenotypic effect on D. rerio of its mis-expression (when available)
Transcription factors
| Gene | Protein name | Expression in EO | Pathway/Function | Disrupted phenotype | Reference |
|---|---|---|---|---|---|
| eng1b | engrailed homeobox 1b | + | neuron fate commitment | ||
| her6 | hairy-related 6 | + | Notch signaling pathway | ||
| hes6 | hes family bHLH transcription factor 6 | + | Notch signaling pathway | ||
| hey1 | hes-related family bHLH transcription factor with YRPW motif 1 | + | Notch signaling pathway | ||
| hipk2 | homeodomain interacting protein kinase 2 | + | Wnt signaling pathway; p53 Signaling; ERK Signaling | Induced apoptosis | [ |
| hoxc11a | homeobox C11a | + | |||
| hoxd11a | homeobox D11a | + | |||
| mef2aa | myocyte enhancer factor 2aa | + | Signaling by FGFR | Abnormal development of posterior somites | [ |
| mef2b | myocyte enhancer factor 2b | + | miRs in Muscle Cell Differentiation | ||
| rb1 | retinoblastoma 1 | + | E2F mediated regulation of DNA replication; Cell cycle | Abnormal retina development | [ |
| taf6 | TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor | + | GPCR Pathway | ||
| arxa | aristaless related homeobox a | - | Axon guidance | Abnormal dopaminergic neurons development | [ |
| klf15 | Kruppel-like factor 15 | - | Adipogenesis | ||
| pbxip1 | pre-B-cell leukemia homeobox interacting protein 1 | - | |||
| myf6 | myogenic factor 6 | - | Myogenesis | Disrupted myogenesis | [ |
| myog | myogenin | - | Myogenesis | Disrupted myogenesis | [ |
| nfatc1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | - | Wnt signaling pathway | ||
| nr0b2a | nuclear receptor subfamily 0, group B, member 2a | - | Nuclear Receptor transcription pathway; NOD-like Receptor Signaling Pathways | ||
| pitx2 | paired-like homeodomain 2 | - | retinoic acid receptor signaling pathway | Abnormal eye and craniofacial development | [ |
| rxrgb | retinoid X receptor, gamma b | - | steroid hormone receptor activity; retinoic acid receptor signaling pathway | ||
| six1b | SIX homeobox 1b | - | regulation of skeletal muscle cell proliferation | Abnormal trunk musculature development | [ |
| six4b | SIX homeobox 4b | - | regulation of skeletal muscle cell proliferation | ||
| tbx15 | T-box 15 | - | regulation of transcription, DNA-templated |
For each of the shared differentially expressed gene are reported: the gene and protein names obtained from the top hit blast results against the proteome of D. rerio; whether it is up(+)- or down(−)- regulated in the EO; its function or pathway (or both when available); the phenotypic effect on D. rerio of its mis-expression (when available)
Cross-species differentially expressed genes with known phenotypic effect
| Gene | Protein | Tissue | Sub-cluster | Phenotype | Source |
|---|---|---|---|---|---|
| nme2b.2 | NME/NM23 nucleoside diphosphate kinase 2b, tandem duplicate 2 | SM | 4 | GTP biosynthesis | ZFIN |
| prkcg | protein kinase C, gamma | EO | 1 | AMPA-R kinetics | ZFIN |
| aco2 | aconitase 2, mitochondrial | EO | 2 | Infantile cerebellar-retinal degeneration | OMIM |
| pdp1 | pyruvate dehyrogenase phosphatase catalytic subunit 1 | EO | 2 | Pyruvate dehydrogenase phosphatase deficiency | OMIM |
| nnt | nicotinamide nucleotide transhydrogenase | EO | 2 | Glucocorticoid deficiency 4 | OMIM |
| sucla2 | succinate-CoA ligase, ADP-forming, beta subunit | EO | 2 | Mitochondrial DNA depletion syndrome 5 | OMIM |
| kcnj11 | potassium inwardly-rectifying channel, subfamily J, member 11 | EO | 2 | Diabetes mellitus | OMIM |
| ippk | inositol 1,3,4,5,6-pentakisphosphate 2-kinase | EO | 2 | Craniofacial development | ZFIN |
| smpd1 | sphingomyelin phosphodiesterase 1, acid lysosomal | EO | 2 | Niemann-Pick disease | OMIM |
| th | tyrosine hydroxylase | EO | 2 | Adult brain function | ZFIN |
| ache | acetylcholinesterase | EO | 2 | Locomotion | ZFIN |
| oxct1a | 3-oxoacid CoA transferase 1a | EO | 2 | Succinyl CoA:3-oxoacid CoA transferase deficiency | OMIM |
| mlycd | malonyl-CoA decarboxylase | EO | 2 | Malonyl-CoA decarboxylase deficiency | OMIM |
| idh1 | isocitrate dehydrogenase 1 (NADP+), soluble | EO | 2 | Susceptibility to glioma | OMIM |
| cpt2 | carnitine palmitoyltransferase 2 | EO | 2 | Myopathy/Encephalopathy | OMIM |
| pltp | phospholipid transfer protein | EO | 2 | HDL cholesterol level | OMIM |
| acat1 | acetyl-CoA acetyltransferase 1 | EO | 2 | Alpha-methylacetoacetic aciduria | OMIM |
| atp1a1a.1 | ATPase, Na+/K+ transporting, alpha 1a polypeptide, tandem duplicate 1 | EO | 3 | Brain development | ZFIN |
| ryr1a | ryanodine receptor 1a (skeletal) | EO | 3 | Myopathy | ZFIN |
| bcl2l10 | BCL2-like 10 (apoptosis facilitator) | EO | 3 | Cytoskeletal activity | ZFIN |
| nalcn | sodium leak channel, non-selective | EO | 3 | Hypotonia | OMIM |
| cngb1a | cyclic nucleotide gated channel beta 1a | EO | 3 | Retinitis pigmentosa 45 | OMIM |
| kcnma1a | potassium large conductance calcium-activated channel, subfamily M, alpha member 1a | EO | 3 | Hearing sensitivity | ZFIN |
| kcnq5b | potassium voltage-gated channel, KQT-like subfamily, member 5b | EO | 3 | Cell membrane excitability | ZFIN |
| nsfa | N-ethylmaleimide-sensitive factor a | EO | 3 | Axon development | ZFIN |
| chrna4b | cholinergic receptor, nicotinic, alpha 4b | EO | 3 | Epilepsy | OMIM |
| adcy1b | adenylate cyclase 1b | EO | 3 | Deafness | OMIM |
| actn2b | actinin, alpha 2b | EO | 3 | Cardiomyopathy | OMIM |
| vmhc | ventricular myosin heavy chain | EO | 3 | Cardiomyopathy | OMIM |
List of cross-species differentially expressed genes belonging to the terms obtained from the enrichment analysis. For each gene, we report: the analysed tissue; the relative sub-cluster as reported in Figs. 6 or 7; and the phenotypic effect of gene function disruption on D. rerio (ZFIN) or Homo sapiens (OMIM)
Fig. 9Assembly schemes for the cross-tissue and cross-species comparison